YieldMax HIMS Option Income Strategy ETF(HIYY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HIYY YieldMax HIMS Option Income Strategy ETF

交易中 04-27 09:34:09 EDT

17.62

-0.27

-1.51%

最高17.62	最低17.61	成交量2,904
今开17.61	昨收17.89	日振幅0.08%
总市值2,643万	流通市值2,643万	总股本150.00万
成交额5.12万	换手率0.19%	流通股本150.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HIYY","market":"US","secType":"STK","nameCN":"YieldMax HIMS Option Income Strategy ETF","latestPrice":17.62,"timestamp":1777296845668,"preClose":17.89,"halted":0,"volume":2904,"delay":0,"changeRate":-0.015092230296254866,"floatShares":1500000,"shares":1500000,"eps":0,"marketStatus":"交易中","change":-0.27,"latestTime":"04-27 09:34:09 EDT","open":17.605,"high":17.62,"low":17.605,"amount":51203.29895999999,"amplitude":0.000838,"askPrice":17.83,"askSize":500,"bidPrice":17.74,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777320000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":17.89,"sharesOutstanding":1150000,"nav":16.66,"aum":24990000,"dividendRate":0.647066,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":18.23,"preClose":17.89,"latestTime":"09:14 EDT","volume":255,"amount":4576.794825,"timestamp":1777295646267,"change":0.34,"changeRate":0.019005,"amplitude":0.021241},"postHourTrading":{"tag":"盘后","latestPrice":17.88,"preClose":17.89,"latestTime":"19:47 EDT","volume":4316,"amount":76472.14,"timestamp":1777074453667,"change":-0.01,"changeRate":-0.000559,"amplitude":0.017887},"volumeRatio":3.038928,"impliedVol":0.2378,"impliedVolPercentile":0.1748},"requestUrl":"/m/hq/s/HIYY","defaultTab":"news","newsList":[{"id":"1196187940","title":"Hims & Hers Health获摩根大通初评“增持” 盘前股价应声上涨2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196187940","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196187940?lang=zh_cn&edition=full","pubTime":"2026-04-24 16:08","pubTimestamp":1777018125,"startTime":"0","endTime":"0","summary":"在摩根大通首次覆盖并给予“增持”评级后，远程医疗服务提供商Hims & Hers Health Inc.股价在盘前交易中应声走高，涨幅达2.2%。\n此次积极的机构评级为该公司股价提供了即时动力，反映出市场对其业务前景的乐观情绪。分析师通常将“增持”评级授予他们预期表现将优于市场平均或行业同行的公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIYY","HIMZ","BK4196","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140294257","title":"Hims & Hers获FDA批准GLP-1疗法：合作医疗机构可为客户开具处方并由独立药房配药","url":"https://stock-news.laohu8.com/highlight/detail?id=1140294257","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140294257?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:45","pubTimestamp":1776948351,"startTime":"0","endTime":"0","summary":"远程医疗平台Hims & Hers Health Inc.宣布，其合作医疗提供者现可为客户开具经美国食品药品监督管理局（FDA）批准的GLP-1类治疗方案。相关药物将由独立药房负责配送供应，确保患者获得持续性的专业医疗支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1b5e0887bced2e980404b6424415259e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","HIMS","HMYY","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113714146","title":"HIMS平台全面上架多款FDA认证的GLP-1药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1113714146","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113714146?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:43","pubTimestamp":1776948205,"startTime":"0","endTime":"0","summary":"4月23日，Hims & Hers Health盘前一度涨超9%，HIMS平台全面上架多款FDA认证的GLP-1药物，涵盖礼来Zepbound针剂、注射笔及Foundayo口服药。","market":"us","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1b5e0887bced2e980404b6424415259e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HIMS平台全面上架多款FDA认证的GLP-1药物","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HIMY","HMYY","HIYY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150435965","title":"期权大单｜获排雷大单催化！Ondas看涨期权占比攀升至80%；与英伟达深化合作！黑莓股价飙升，期权成交量激增","url":"https://stock-news.laohu8.com/highlight/detail?id=1150435965","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150435965?lang=zh_cn&edition=full","pubTime":"2026-04-21 10:10","pubTimestamp":1776737410,"startTime":"0","endTime":"0","summary":"期权方面，Ondas当日成交近50万张，较90日均量放大逾2倍，看涨期权占比攀升至近80%，其中于4月24日到期的11美元行使价的看涨期权成交居前，成交近4万张。这一组合旨在开发安全可靠的AI解决方案，以满足严格的安全标准，应对日益增长的边缘AI技术需求。根据披露的细节，此次洽谈的核心围绕两款旨在显著提升 AI 模型运行效率的新型芯片。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"324431b18d184842b2237adf08e51534","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONDG","HIYY","ONDS","MRVU","HIMY","MVLL","HIMZ","ONDL","HMYY","HIMS","MRVL","ONDU","BB"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1118801610","title":"美股夜盘 | HIMS续涨10%，Robinhood续涨3%；量子计算、核电股续涨，SMR涨近5%，IONQ涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118801610","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118801610?lang=zh_cn&edition=full","pubTime":"2026-04-16 08:16","pubTimestamp":1776298576,"startTime":"0","endTime":"0","summary":"4月16日，美股夜盘时段，量子计算概念股续涨，$D-Wave Quantum(QBTS)$、$Arqit Quantum(ARQQW)$、IONQ涨超3%，$Quantum Computing(QUBT)$涨近3%，$Rigetti Computing(RGTI)$涨近2%。核电股$NuScale Power(SMR)$续涨近5%，Oklo涨超3%。平价减肥药供应商$Hims & Hers Health(HIMS)$续涨超10%，FDA正式官宣7月召开专家会议，敲定肽类药物全面松绑细节。$Robinhood(HOOD)$续涨超3%，美国SEC批准取消投资者日内交易限制的计划。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f2325dda5620875f8564357c4c565fe1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["URAN","HODU","IONX","HOOD","BK4127","BK4539","HMYY","SMU","BK4588","DRLL","IONZ","HOOI","HOYY","BK4196","BK4608","IONQ.WS","IOYY","SMR","LU1861559042.SGD","BK4170","BK4547","NUKZ","HIMZ","HOOW","HOOG","SMUP","LU1861558580.USD","IONQ","BK4585","QTUM","BK4182","BK4591","QPUX","BK4602","HIMS","HOOZ","HOOX","BK4023","HOOY","NLR","HOII","URNM","ROBN","SMZ","HIMY","IONL","BK4606","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155256862","title":"Hims & Hers Health公司回应：已着手审查受影响的客服工单，以确定所涉信息内容及关联对象","url":"https://stock-news.laohu8.com/highlight/detail?id=1155256862","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155256862?lang=zh_cn&edition=full","pubTime":"2026-04-03 05:40","pubTimestamp":1775166038,"startTime":"0","endTime":"0","summary":"作为应对措施，Hims & Hers Health Inc. 已启动对相关服务工单的全面审查。此项审查旨在明确工单中所包含的具体信息内容，并进一步厘清这些信息所关联的个体或实体。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMS","HIYY","BK4196","HIMZ","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176598401","title":"Hims & Hers Health Inc. 携手Cyberscout提供12个月免费信用监控与身份恢复服务","url":"https://stock-news.laohu8.com/highlight/detail?id=1176598401","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176598401?lang=zh_cn&edition=full","pubTime":"2026-04-03 05:40","pubTimestamp":1775166032,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 宣布，将通过专业身份保护服务商Cyberscout，为客户提供为期12个月的免费信用监控及身份恢复服务。这项举措旨在为用户的信息安全提供额外保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMS","HIYY","BK4196","HIMZ","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185807034","title":"Hims & Hers Health：用户医疗记录未受事件影响，平台医患沟通亦保持正常","url":"https://stock-news.laohu8.com/highlight/detail?id=1185807034","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185807034?lang=zh_cn&edition=full","pubTime":"2026-04-03 05:40","pubTimestamp":1775166027,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 近日发布声明，确认其平台上的用户医疗记录在此次事件中未受影响。同时，用户与医疗保健提供者通过平台进行的沟通交流也未受到波及。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","BK4196","HIMS","HMYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113377483","title":"Hims & Hers Health Inc于3月3日确认受影响服务工单中包含少量用户个人信息","url":"https://stock-news.laohu8.com/highlight/detail?id=1113377483","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113377483?lang=zh_cn&edition=full","pubTime":"2026-04-03 05:39","pubTimestamp":1775165967,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc于3月3日披露，在受影响的系统服务工单中，识别出涉及少量特定个人的相关信息。该公司表示已采取相应措施处理该事件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4196","HIMZ","HMYY","HIMS","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116739908","title":"Hims & Hers Health：2月5日发现影响第三方客服平台的异常活动","url":"https://stock-news.laohu8.com/highlight/detail?id=1116739908","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116739908?lang=zh_cn&edition=full","pubTime":"2026-04-03 05:39","pubTimestamp":1775165955,"startTime":"0","endTime":"0","summary":"数字健康服务提供商Hims & Hers Health Inc. (HIMS) 于2月5日披露，公司监测到其第三方客户服务平台出现可疑活动，目前正对此展开调查。该事件可能涉及客户数据安全，公司表示已启动应急响应程序，并与相关合作伙伴协同处理，以评估潜在影响并保障用户信息安全。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMS","HMYY","BK4196","HIMY","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136041471","title":"诺和诺德：Wegovy订阅计划将于3月31日起通过Ro、WeightWatchers和LifeMD提供","url":"https://stock-news.laohu8.com/highlight/detail?id=1136041471","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136041471?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:34","pubTimestamp":1774956843,"startTime":"0","endTime":"0","summary":"诺和诺德公司宣布，其备受关注的减肥药物Wegovy订阅服务将从3月31日起正式上线。该计划将通过数字健康平台Ro、体重管理服务商WeightWatchers以及远程医疗提供商LifeMD向用户开放。\n这一举措标志着诺和诺德在拓宽Wegovy可及性方面迈出重要一步。通过与合作方联手，患者将能更便捷地获得这款GLP-1受体激动剂药物的专业指导和支持服务。\n订阅计划的推出正值减肥药物市场需求激增之际。分析认为，这种创新服务模式有望帮助更多肥胖症患者获得规范治疗，同时强化诺和诺德在代谢疾病领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea115adc665c74e6a4a5582f9333b9fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIYY","NVO","HIMZ","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111906858","title":"诺和诺德：Wegovy口服药9毫克及25毫克剂量推出订阅计划，3个月套餐每月289美元、6个月套餐每月269美元、12个月套餐每月249美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111906858","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111906858?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:33","pubTimestamp":1774956827,"startTime":"0","endTime":"0","summary":"诺和诺德（Novo Nordisk）近日宣布，其备受关注的Wegovy口服药已推出灵活订阅方案，涵盖9毫克和25毫克两种剂量规格。用户现可选择3个月、6个月或12个月的不同订阅周期，享受阶梯式价格优惠：3个月套餐月费为289美元，6个月套餐月费降至269美元，而12个月长期订阅更可享每月249美元的超值价格。这一订阅模式旨在为长期体重管理需求者提供更可持续的经济选择，同时强化药物使用的连续性。随着Wegovy口服版本在减重市场的持续渗透，诺和诺德正通过多元化的支付策略进一步扩大其用户基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea115adc665c74e6a4a5582f9333b9fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIYY","HMYY","NVO","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182181386","title":"Hims & Hers平台扩容：将引入Wegovy与Ozempic减重药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1182181386","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182181386?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:52","pubTimestamp":1773838324,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc.宣布，其服务平台将扩大产品范围，纳入诺和诺德旗下的Wegovy口服片剂与注射剂，以及Ozempic注射剂。这两款药物均属于GLP-1受体激动剂，主要用于体重管理与2型糖尿病治疗。此次引入Wegovy与Ozempic，标志着Hims & Hers正式切入规模快速扩张的GLP-1减重药物市场。Hims & Hers此前主要提供毛发护理、皮肤健康与心理健康服务，此次拓展是其向慢病管理领域迈出的重要一步。消息公布后，Hims & Hers股价在盘前交易中小幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIYY","BK4196","HIMS","HMYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618138250","title":"Hims & Hers Health(HIMS)盘前涨8% 日前与诺和诺德建立新的合作伙伴关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138250","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138250?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:08","pubTimestamp":1773310089,"startTime":"0","endTime":"0","summary":"金吾财讯 | Hims & Hers Health 盘前涨8%，截至发稿，报27.950美元。消息面上，日前，Hims & Hers Health与诺和诺德建立新的合作伙伴关系，专注于提供品牌药物。两家公司于周一表示，诺和诺德已同意在Hims & Hers Health平台上销售其王牌药物Ozempic和Wegovy，其中包括备受欢迎的Wegovy口服片剂。同时，诺和诺德将撤回上个月针对Hims & Hers Health提起的诉讼。作为回报，Hims & Hers Health表示将不再为其仿制版诺和诺德药物投放广告。但如果医生认为患者有必要使用，该公司仍将销售Wegovy和Ozempic的复配版本。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/ZTgzYzFjMzMwYjg4MjEzNTY0MzUzNDIy.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZTgzYzFjMzMwYjg4MjEzNTY0MzUzNDIy.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"297963","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","HIMS","LU0154236417.USD","BK4532","LU1093756325.SGD","NVOX","LU1093756168.USD","BK4007","BK4196","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","HIMZ","HMYY","HIYY","HIMY","NVOH","BK4599","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106846919","title":"盘前异动 | 石油股上涨，Battalion Oil涨近8%；HIMS续涨逾5%，本田汽车跌超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106846919","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106846919?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:07","pubTimestamp":1773302874,"startTime":"0","endTime":"0","summary":"3月12日，美股三大股指期货下跌，截止发稿，道指期货跌0.60%，纳指期货跌0.45%，标普500指数期货跌0.48%。部分石油股盘前上涨，$Battalion Oil(BATL)$涨近8%，$美国能源(USEG)$涨近5%；$Hims & Hers Health(HIMS)$续涨逾5%，本周三个交易日已累涨约64%。部分加密货币概念股盘前下跌，$BitMine Immersion(BMNR)$跌超4%，$Coinbase(COIN)$、$Robinhood(HOOD)$跌超1%。本田汽车盘前跌超8%，因重新考虑其电车战略而计提高达约157亿美元的费用。 ","market":"us","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e4d6689b7a260553016615cecc1fd48b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEAM","BK4588","BK4196","BK4585","BK4570","BK4099","BMBL","HIYY","HIMY","XOP","HIMS","HIMZ","BATL","HMC","BK4555","XLE","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618918759","title":"Hims & Hers(HIMS.US)挖角礼来公关大将！剑指品牌减肥药新战场","url":"https://stock-news.laohu8.com/highlight/detail?id=2618918759","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618918759?lang=zh_cn&edition=full","pubTime":"2026-03-11 10:22","pubTimestamp":1773195738,"startTime":"0","endTime":"0","summary":"此前，Hims & Hers HealthHims因销售热门减肥药的仿制版本而面临日益增加的法律和监管压力。Hims & Hers Health表示，公司将通过与礼来的主要竞争对手诺和诺德建立新的合作伙伴关系，专注于提供品牌药物。两家公司于周一表示，诺和诺德已同意在Hims & Hers Health平台上销售其王牌药物Ozempic和Wegovy，其中包括备受欢迎的Wegovy口服片剂。同时，诺和诺德将撤回上个月针对Hims & Hers Health提起的诉讼。作为回报，Hims & Hers Health表示将不再为其仿制版诺和诺德药物投放广告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2087625088.SGD","LU2023250504.SGD","LU2237443382.USD","BK4585","LU0882574139.USD","LU2237443622.USD","LU0320765992.SGD","LU2236285917.USD","LU2023251221.USD","IE00BJJMRX11.SGD","LU0256863902.USD","IE0001KFT4U8.USD","SGXZ51526630.SGD","LU0820561818.USD","LU1804176565.USD","LU2491050071.SGD","LU0456855351.SGD","LU2491050154.USD","LU2461242641.AUD","LU2089283258.USD","LU2750360997.AUD","LU2361044865.SGD","LU0882574055.USD","LU0158827781.USD","SG9999014898.SGD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4534","HIYY","LU0672654240.SGD","LU0385154629.USD","LU2361044949.HKD","LU2417539215.USD","IE0005OL40V9.USD","LU2237443465.HKD","SG9999001176.USD","LLYZ","ELIL","LU0316494557.USD","LU0289739699.SGD","IE00BKDWB100.SGD","LU1551013342.USD","LU0689472784.USD","LU2023250330.USD","IE00BWXC8680.SGD","LU2746668461.USD","LU0122379950.USD","LU2750360641.GBP","LU1712237335.SGD","LU0683600562.USD","SG9999015978.USD","LU2089984988.USD","SG9999018857.SGD","LU2028103732.USD","LU0353189680.USD","LU1069344957.HKD","HIMZ","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU0109391861.USD","BK4533","SGXZ31699556.SGD","LU0238689110.USD","LU1093756325.SGD","LU1720051017.SGD","SG9999014914.USD","SG9999017495.SGD","LU2602419157.SGD","SG9999014906.USD","IE0009355771.USD","LU1917777945.USD","LU0432979614.USD","LU1868836591.USD","LU0353189763.USD","LU2237443895.HKD","SG9999014880.SGD","LU1267930730.SGD","IE00B2B36J28.USD","IE00B7KXQ091.USD","LU0708995401.HKD","BK4581","LU2462157665.USD","LU1145028129.USD","BK4196","LU2271345857.HKD","LU2552382058.USD","ELIS","LU2168564065.EUR","LU0061475181.USD","LU0203202063.USD","LU0471298694.HKD","LU1093756168.USD","IE00B1XK9C88.USD","LU0234572021.USD","LU0820562030.AUD","IE0002141913.USD","LU0225283273.USD","LU0266013472.USD","LU1989771016.USD","LU1983299246.USD","LU2213496289.HKD","LU2896262040.SGD","IE00BJLML261.HKD","LU2491049909.HKD","LU0106261372.USD","LU1023059063.AUD","LU1127390331.HKD","LU0203201768.USD","LU1720051108.HKD","SGXZ57979304.SGD","LU1551013425.SGD","SG9999015945.SGD","BK4599","HMYY","LU0097036916.USD","LU0006306889.USD","LU0096364046.USD","LU2746668974.SGD","LU0114720955.EUR","LU1868837300.USD","IE00BJT1NW94.SGD","LU1623119135.USD","LU2360106947.USD","LU1814569148.SGD","HIMY","SG9999018865.SGD","IE00BKPKM429.USD","LLYX","SG9999013999.USD","LU0823416689.USD","LU1057294990.SGD","LU0417517546.SGD","LU2361045086.USD","LU2756315318.SGD","LU0640476718.USD","LU1629891620.HKD","LU1064131342.USD","BK4588","IE00BN29S564.USD","LU2237443978.SGD","LU2265009873.SGD","LU1974910355.USD","LU2237443549.SGD","LU0094547139.USD","LU0158827948.USD","LU2552382132.HKD","IE00BFSS7M15.SGD","LU0820561909.HKD","LU0964807845.USD","LU2168564222.USD","SG9999001176.SGD","LU0320765059.SGD","LU2108987350.USD","LU1280957306.USD","LU0058720904.USD","LU0823434583.USD","LU0354030438.USD","LU0323591593.USD","LU1548497426.USD","LU0943347566.SGD","LU2468319806.SGD","LU1988902786.USD","LU2106854487.HKD","LU2168564149.EUR","LU2111349929.HKD","BK4007","IE00B1BXHZ80.USD","LU2063271972.USD","IE00B4R5TH58.HKD","LU0354030511.USD","LU1291159041.SGD","LU2552382215.SGD","LU2168563687.JPY","IE0004445239.USD","LU2168564495.EUR","LU2471134523.USD","LU2471134952.CNY","LU2471134796.USD","BK4516","LU1035775433.USD","LU0787776722.HKD","LU0786609619.USD","LU1366192091.USD","LLII","LU0198837287.USD","LU1868836914.USD","LU0079474960.USD","LU0256863811.USD","LU0823434740.USD","SG9999015952.SGD","SGXZ99366536.SGD","LU2237438978.USD","LU2264538146.SGD","LU2112291526.USD","LU1323610961.USD","GB00BDT5M118.USD","SG9999015986.USD","LU1868837136.USD","LU0466842654.USD","LU0109394709.USD","LU2471134879.HKD","LU1868836757.USD","LU2324357040.USD","LU0471298777.SGD","LU0210536198.USD","IE00BK4W5L77.USD","LU2089284900.SGD","IE00B4JS1V06.HKD","IE00BFSS8Q28.SGD","LU2211815571.USD","HIMS","LU2456880835.USD","IE00B775H168.HKD","LU1232071149.USD","LU1061106388.HKD","IE0004445015.USD","LU2357305700.SGD","LU2756315664.SGD","IE00BK4W5M84.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1126668487","title":"花旗集团上调Hims & Hers Health Inc评级至中性，目标价大幅提升至24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126668487","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126668487?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:27","pubTimestamp":1773138443,"startTime":"0","endTime":"0","summary":"花旗集团最新发布的研究报告显示，已将对远程医疗公司Hims & Hers Health Inc的股票评级从\"卖出\"上调至\"中性\"。与此同时，该机构将其目标股价从13.25美元显著调高至24美元，涨幅超过80%。\n此次评级调整反映了花旗对该公司业务发展前景的重新评估。目标价的大幅提升可能基于对公司营收增长、市场份额扩大或盈利能力改善的积极预期。作为专注于男性与女性健康领域的远程医疗服务商，Hims & Hers Health Inc近期在扩大用户基础和优化服务模式方面取得进展，这或是引发机构重新评估其价值的关键因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"05b47021c469e7d3f1884b07d446c55d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMZ","HIMY","BK4196","HIMS","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618147987","title":"花旗上调Hims & Hers Health(HIMS.US)评级至“中性” 看好诺和诺德协议下的合规溢价","url":"https://stock-news.laohu8.com/highlight/detail?id=2618147987","media":"智通财经","labels":["executive","rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618147987?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:07","pubTimestamp":1773130046,"startTime":"0","endTime":"0","summary":"花旗银行在最新的研究报告中对这一合作给予了高度评价，并将其视为 Hims & Hers 发展史上的重要转折点。花旗分析师指出，通过引入官方正版药物，Hims & Hers 成功摆脱了长期困扰其业务模式的合规性阴影与法律风险。这一利好消息在二级市场引发了剧烈反弹，Hims & Hers 的股价在消息公布后的交易时段内一度飙升超过 35%，周一收涨40.79%，报22.16美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"5cccc8ba7a9e8bd0cd40ca1f6c5f84c3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,rating","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4599","LU1244550494.USD","LU2125154935.USD","LU0130517989.USD","LU0980610538.SGD","LU0170899867.USD","BK4196","LU0072461881.USD","NVOX","LU1668664300.SGD","IE00BKVL7J92.USD","LU1201861249.SGD","HIYY","BK4588","LU0477156953.USD","NVOH","LU1267930227.SGD","BK4532","LU1366192091.USD","LU0098860793.USD","IE00BSNM7G36.USD","LU2456880835.USD","LU1244550577.SGD","LU0162691827.USD","LU1506573853.SGD","LU0052756011.USD","LU1791807156.HKD","LU2125154778.USD","LU1093756325.SGD","LU0648001328.SGD","LU0314106906.USD","LU0128525689.USD","BK4534","BK4504","HIMY","IE00BZ1G4Q59.USD","HIMZ","LU2236285917.USD","LU2417539215.USD","LU0130102774.USD","HMYY","BK4007","LU1244550221.USD","LU2360032135.SGD","BK4559","LU2462157665.USD","BK4566","HIMS","LU0320765646.SGD","BK4585","LU1093756168.USD","BK4207","LU0310800965.SGD","LU0106831901.USD","LU1162221912.USD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1177597123","title":"ETF日报｜2倍做多Hims & Hers ETF涨超81%；三倍做多半导体ETF涨超11%；成长风格领跑","url":"https://stock-news.laohu8.com/highlight/detail?id=1177597123","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177597123?lang=zh_cn&edition=full","pubTime":"2026-03-10 10:30","pubTimestamp":1773109800,"startTime":"0","endTime":"0","summary":"大宗商品中，白银相关ETF显著走强，原油做多品种回落。该产品两倍做多在线医疗平台公司$Hims & Hers Health$，因底层公司股价上涨，杠杆机制放大当日涨幅。$诺和诺德$计划在Hims & Hers Health平台销售减重药物，双方结束此前的法律纠纷，公司股价大幅上涨。该产品围绕Hims & Hers Health开展期权收益策略，因公司股价上行，份额净值同步走高。$2倍做多恐慌指数期货ETF$下跌19.40%。行业指数ETF涨幅Top 5$三倍做多半导体ETF-Direxion Daily$上涨11.34%。债券ETF涨幅Top 5$First Trust SSI Strategic Convertible Securities ETF$上涨2.02%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6ff7c068e21399ce793d8151cce49f41","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TUR","LU0444973449.USD","LU1642822529.SGD","LU2294711713.HKD","HIMZ","LU2357125470.USD","TQQQ","CRCD","LU0444971666.USD","ICVT","HIMS","NUGT","LU0823414478.USD","BK4585","LU2249611893.SGD","UVIX","RCAX","BMNZ","HIYY","LU0957808578.USD","LU2506951792.HKD","LITE","RDWU","BMNR","SMH","IBB","BE","LU1064131342.USD","LU2264538146.SGD","AGQ","CRCL","LITX","LU2543165471.USD","BK4182","BEZ","LU0476273544.USD","DGZ","FCVT","LU0823414551.USD","OIH","SOXL","RDW","SLV","SPLB","YINN","EWY","CWB","BK4541","LU1815336760.USD","XLK","NLR","EDC","BK4588","BEG","BK4550","VCLT","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618672446","title":"3月10日美股成交额前20：HIMS与诺和诺德达成合作，股价大涨逾40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618672446","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618672446?lang=zh_cn&edition=full","pubTime":"2026-03-10 04:48","pubTimestamp":1773089280,"startTime":"0","endTime":"0","summary":"周一美股成交额第1名英伟达收高2.72%，成交313.6亿美元。亿万富豪廖凯原周一再度增持英伟达，将其持股数量翻倍至200万股。　　摩尔维持对博通的“买入”评级，将其目标价从462美元上调至470美元，意味着约42%的上涨空间。　　此外，3月2日，英伟达宣布投资20亿美元并与Lumentum达成多年战略合作，包括数十亿美元采购高端激光元件的承诺，聚焦AI数据中心光学技术。　　该消息公布后，诺和诺德撤销了对该公司的诉讼，标志着双方争端的结束。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2125f643a531f294312a5aa84a9983ad","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-10/doc-inhqmumf6558599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVO","HIYY","BK4196","HIMY","BK4599","IE00BKVL7J92.USD","BK4585","LU1093756168.USD","IE00BZ1G4Q59.USD","HMYY","HIMS","BK4007","LU0154236417.USD","NVOH","BK4588","HIMZ","LU1093756325.SGD","NVOX","BK4532"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0142},{"period":"1month","weight":0.2432},{"period":"3month","weight":-0.1853},{"period":"6month","weight":-0.5482},{"period":"1year","weight":-0.6302},{"period":"ytd","weight":-0.2733}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"YieldMax HIMS Option Income Strategy ETF","nameEN":"YieldMax HIMS Option Income Strategy ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"YieldMax HIMS Option Income Strategy ETF(HIYY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供YieldMax HIMS Option Income Strategy ETF(HIYY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"YieldMax HIMS Option Income Strategy ETF,HIYY,YieldMax HIMS Option Income Strategy ETF股票,YieldMax HIMS Option Income Strategy ETF股票老虎,YieldMax HIMS Option Income Strategy ETF股票老虎国际,YieldMax HIMS Option Income Strategy ETF行情,YieldMax HIMS Option Income Strategy ETF股票行情,YieldMax HIMS Option Income Strategy ETF股价,YieldMax HIMS Option Income Strategy ETF股市,YieldMax HIMS Option Income Strategy ETF股票价格,YieldMax HIMS Option Income Strategy ETF股票交易,YieldMax HIMS Option Income Strategy ETF股票购买,YieldMax HIMS Option Income Strategy ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"YieldMax HIMS Option Income Strategy ETF(HIYY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供YieldMax HIMS Option Income Strategy ETF(HIYY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}